Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P65
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -0.62% |
| Q3 2025 | -19.24% |
| Q2 2025 | -119.42% |
| Q1 2025 | 666.71% |
| Q4 2024 | -6.98% |
| Q3 2024 | -23.94% |
| Q2 2024 | 28.70% |
| Q1 2024 | -17.72% |
| Q4 2023 | -18.32% |
| Q3 2023 | 22.06% |
| Q2 2023 | -5.19% |
| Q1 2023 | 5.54% |
| Q4 2022 | 5.41% |
| Q3 2022 | -16.87% |
| Q2 2022 | -165.12% |
| Q1 2022 | 292.27% |
| Q4 2021 | -10.07% |
| Q3 2021 | 8.54% |
| Q2 2021 | 19.61% |
| Q1 2021 | -84.56% |
| Q4 2020 | 1.09% |
| Q3 2020 | -14.55% |
| Q2 2020 | 14.53% |
| Q1 2020 | -5.68% |
| Q4 2019 | -24.77% |
| Q3 2019 | -29.48% |
| Q2 2019 | -0.63% |
| Q1 2019 | -83.59% |
| Q4 2018 | -1.43% |
| Q3 2018 | -30.82% |
| Q2 2018 | -34.94% |
| Q1 2018 | 0.00% |